Evidence map›Paper›PMID 31029080›Full record

ArticleBMC bioinformatics2019

DNAscan: personal computer compatible NGS analysis, annotation and visualisation.

A Iacoangeli, A Al Khleifat, W Sproviero, A Shatunov, A R Jones, S L Morgan, A Pittman, R J Dobson, S J Newhouse, A Al-Chalabi

Abstract read
In one paragraph

Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Accelerating BWA-MEM Read Mapping on GPUs.ICS ... : proceedings of the ... ACM International Conference on Supercomputing. International Conference on Supercomputing · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

A IacoangeliDepartment of Biostatistics and Health Informatics, King's College London, London, UK. alfredo.iacoangeli@kcl.ac.uk.ORCID http://orcid.org/0000-0002-5280-5017
A Al KhleifatDepartment of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
W SprovieroDepartment of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
A ShatunovDepartment of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
A R JonesDepartment of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
S L MorganDepartment of Molecular Neuroscience, UCL, Institute of Neurology, London, UK.
A PittmanDepartment of Molecular Neuroscience, UCL, Institute of Neurology, London, UK.
R J DobsonDepartment of Biostatistics and Health Informatics, King's College London, London, UK.
S J NewhouseDepartment of Biostatistics and Health Informatics, King's College London, London, UK.
A Al-ChalabiDepartment of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.

Funding

Medical Research Council G0600974Medical Research Council MC_PC_17214Medical Research Council MR/L501529/1Medical Research Council MR/R024804/1Motor Neurone Disease Association AL-CHALABI/APR15/844-791Motor Neurone Disease Association ALCHALABI-DOBSON/APR14/829-791Wellcome Trust
6 · The paper itself

Abstract

backgroundNext Generation Sequencing (NGS) is a commonly used technology for studying the genetic basis of biological processes and it underpins the aspirations of precision medicine. However, there are significant challenges when dealing with NGS data. Firstly, a huge number of bioinformatics tools for a wide range of uses exist, therefore it is challenging to design an analysis pipeline. Secondly, NGS analysis is computationally intensive, requiring expensive infrastructure, and many medical and research centres do not have adequate high performance computing facilities and cloud computing is not always an option due to privacy and ownership issues. Finally, the interpretation of the results is not trivial and most available pipelines lack the utilities to favour this crucial step.

resultsWe have therefore developed a fast and efficient bioinformatics pipeline that allows for the analysis of DNA sequencing data, while requiring little computational effort and memory usage. DNAscan can analyse a whole exome sequencing sample in 1 h and a 40x whole genome sequencing sample in 13 h, on a midrange computer. The pipeline can look for single nucleotide variants, small indels, structural variants, repeat expansions and viral genetic material (or any other organism). Its results are annotated using a customisable variety of databases and are available for an on-the-fly visualisation with a local deployment of the gene.iobio platform. DNAscan is implemented in Python. Its code and documentation are available on GitHub: https://github.com/KHP-Informatics/DNAscan . Instructions for an easy and fast deployment with Docker and Singularity are also provided on GitHub.

conclusionsDNAscan is an extremely fast and computationally efficient pipeline for analysis, visualization and interpretation of NGS data. It is designed to provide a powerful and easy-to-use tool for applications in biomedical research and diagnostic medicine, at minimal computational cost. Its comprehensive approach will maximise the potential audience of users, bringing such analyses within the reach of non-specialist laboratories, and those from centres with limited funding available.

Indexed as

High-Throughput Nucleotide SequencingUser-Computer InterfaceAmyotrophic Lateral SclerosisComputational BiologyDatabases, FactualDNA, BacterialHIV-1HumansINDEL MutationPolymorphism, Single NucleotideRNA, ViralWhole Genome SequencingDNA, BacterialRNA, ViralAnnotationBioinformaticsNext generation sequencingRepeat expansionStructural variantsVariant callingViral detection

Identifiers

PMID31029080
PMCPMC6487045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.